key: cord-0810846-v6px02zf
authors: Singh, Gurmeet; Nahirniak, Susan; Arora, Rakesh; Légaré, Jean-François; Kanji, Hussein; Nagpal, Dave; Lamarche, Yoan; Fan, Eddy; Singh Parhar, Ken Kuljit
title: TRANSFUSION THRESHOLDS FOR ADULT RESPIRATORY EXTRACORPOREAL LIFE SUPPORT: AN EXPERT CONSENSUS DOCUMENT
date: 2020-06-26
journal: Can J Cardiol
DOI: 10.1016/j.cjca.2020.06.014
sha: 537ddc83733e1cca70f2b5903687fd4415adae78
doc_id: 810846
cord_uid: v6px02zf

Severe acute respiratory distress syndrome (ARDS) can complicate novel pandemic coronavirus disease (COVID-19). Extracorporeal life support (ECLS) represents the final possible rescue strategy. Variations in practice, combined with a paucity of rigorous guidelines, may complicate blood product resource availability and allocation during a pandemic. We conducted a literature review around venovenous extracorporeal membrane oxygenation (VV-ECMO) transfusion practices for platelets, packed red blood cells, fresh frozen plasma, prothrombin complex concentrate, and antithrombin. Pertinent society guidelines were examined, and the practice of Canadian ECLS experts was sampled through an environmental scan. This paper represents a synthesis of these explorations, combined with input from the Canadian Cardiovascular Critical Care (CANCARE) Society, Canadian Society of Cardiac Surgeons, and the Canadian Critical Care Society. We offer a pragmatic guidance document for restrictive transfusion thresholds in non-bleeding VV-ECMO patients, which may attenuate transfusion-related complications, and simultaneously shield national blood product inventory from strain during pandemic-induced activation of the National Plan for the Management of Shortages of Labile Blood Components.

Transfusion Thresholds for VV-ECMO

Gurmeet Singh ECLS, although an effective rescue therapy, is resource intensive. Of particular concern is blood product transfusion needs during extracorporeal support, and implications on dwindling or depleted national inventory during a pandemic.

implications is evolving, which may influence blood product transfusion thresholds.

Several drivers exist for blood product utilization during ECLS.

Both bleeding and thrombosis are potential patient and circuit complications. The antagonism of bleeding diatheses and circuit thrombosis necessitates a balanced approach between blood product administration and anticoagulation. Furthermore, one of the physiologic goals of ECLS includes increasing oxygen delivery to overcome profound tissue hypoxia. Since oxygen delivery is influenced by oxygen saturation and hemoglobin (in addition to cardiac output), clinicians traditionally transfused to higher hemoglobin targets to augment oxygen delivery.

Galen's admonition on the value of a remedy may be reflected in Due to a paucity of data and based on expert consensus, we suggest:

Routine use of antifibrinolytic agents is not indicated, 1. No current consensus exists amongst ECLS centres in regard to antithrombin monitoring or repletion. Some programs elect to replace antithrombin when heparin resistance is a clinical concern; that is, suboptimal anticoagulation targets, low 

Page 19 of 21 VV-ECMO is often a viable rescue therapy for severe ARDS.

Unfortunately, there are a paucity of robust data to guide blood product transfusion practices in this population. In a pandemic context, the potential exists for blood product supply exhaustion.

We propose that a restrictive approach to transfusion for stable, non-bleeding patients on VV-ECMO can be safely applied.

Such a strategy may prevent unnecessary transfusions, with the known associated harms, and also mitigate consumption of essential blood product inventory.

Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions

Extracorporeal Life Support Organization (ELSO)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

Blood Conservation in Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. The Annals of Thoracic Surgery

The authors wish to thank Dr. Bojan Paunovic and Dr. Bram Rochwerg (Canadian Critical Care Society) for their input and contribution to the manuscript.